Companies /Healthcare

Penumbra Inc

NYSE: PEN Medical Devices
$319.57
▲ $0.31 (+0.10%) today
Markets closed · 11:58pm ET
Today · % change

24/7 Wall St. View

Fundamentals

Market Cap
$12.6B
P/E Ratio
78.8
Profit Margin
10.7%
Revenue (TTM)
$1.5B
EPS (TTM)
$4.05
52-Week Range
$221 – $362
Street Target
$361.83

About Penumbra

Penumbra Inc is a pioneering medical device company based in Alameda, California, specializing in innovative solutions for neurovascular and peripheral vascular conditions. Its product lineup includes the Indigo System for clot removal, various thrombectomy systems like Lightning Flash and Lightning Bolt 7, and the Penumbra System for mechanical thrombectomy. Additionally, Penumbra offers neuro embolization coils, peripheral embolization products, and cutting-edge neurosurgical tools. With a focus on improving patient outcomes, Penumbra's products are distributed globally, serving healthcare professionals and patients with advanced medical technology since 2004.

PEN Coverage